Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuraxial Ultrasound Device Study

NCT: NCT06281249 · NOT_YET_RECRUITING

NCT IDNCT06281249
StatusNOT_YET_RECRUITING
Start Date2026-12-15
Completion2027-12

Brief Summary

The aim of the study is to develop a device that can eliminate failed neuraxial placements in challenging patients.The study will attempt to improve safety and efficacy of neuraxial anesthesia with high precision real-time needle visualization through automated real-time needle guidance at the bedside with an experimental device (Accuro 3S). Investigators will verify the clinical workflow for utilizing the Accuro 3S during epidural and spinal procedures and validation of needle visualization while using the device as well as anatomical guidance provided by the device during spinal imaging.The underlying bone imaging enhancement algorithms were introduced in the commercially available FDA approved Accuro. The Accuro 3S will be used to establish needle insertion point and trajectory, after which the clinician will use standard of care methods to advance the needle such as the loss of resistance method.

Frequently Asked Questions

What is Neuraxial Ultrasound Device Study?

Neuraxial Ultrasound Device Study is a clinical trial registered under NCT06281249. Current status: NOT_YET_RECRUITING.

What is the status of NCT06281249?

The current status of NCT06281249 (Neuraxial Ultrasound Device Study) is: NOT_YET_RECRUITING.

When did Neuraxial Ultrasound Device Study start?

Neuraxial Ultrasound Device Study started on 2026-12-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.